Emerging Therapies for Pulmonary Fibrosis for Scleroderma Patients

admin avatar

by admin |

Share this article:

Share article via email

Dr. Paul Wolters, Director of Biological Research for the Interstitial Lung Disease Program at the University of California, San Francisco (UCSF) – “Emerging Therapies in Pulmonary Fibrosis: Their Relevance for Scleroderma Patients” will educate a broad audience on the diagnosis and importance of early management of scleroderma.

Learn more about scleroderma here: http://bit.ly/learnscleroderma